参考文献/References:
［1］侯自红，吴尚纯，顾向应．产后和流产后使用长效可逆避孕方法的技术指南 ［J］．国际生殖健康/计划生育杂志，2013，32（4）：267-268, 289．
［2］JACKSON E, GLASIER A. Return of ovulation and menses in postpartum nonlactating women ：a systematic review ［J］. Obstetrics and Gynecology, 2011, 117 (3): 657-662.
［3］Gray RH, Campbell OM, Apelo R, et al. Risk of ovulation during lactation ［J］. Lancet， 1990, 335（8680）:25-29.
［4］WHO.Adolescent pregnancy ［EB/OL］ ［2018-12-07］.
［5］SANTELLI J S, LINDBERG L D, FINER L B, et al. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use ［J］. American Journal of Public Health, 2007, 97 (1): 150-156.
［6］National Institute for Clinical Excellence(NICE)．Long-acting reversible contraception：The effective and appropriate use of long—acting reversible contraception ［M］．NICE，London，2005：1.
［7］BIRGISSON N E, ZHAO Qiu-hong, SECURA G M, et al. Preventing unintended pregnancy: the contraceptive CHOICE project in review ［J］. Journal of Women's Health, 2015, 24 (5): 349-353.
［8］WHO/RHP．吴尚纯,王士娴.中国提高其IUD技术等级 ［J］．中国计划生育学杂志，2003，11（4）：222-224．
［9］国家十五攻关课题．“IUD失败原因和预防对策研究”课题组.月经间期放置7种宫内节育器的临床效果比较 ［J］．中国计划生育学杂志，2008，16（9）：552-556．
［10］American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception ［J］. ObstetGynecol，2016，128（2）:e 32.
［11］OGBURN J A, ESPEY E, STONEHOCKER J. Barriers to intrauterine device insertion in postpartum women ［J］. Contraception, 2005, 72 (6): 426-429.
［12］Baldwin MK, Edelman AB, Lim JY, et al. Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial ［J］. Contraception，2016，93（4）:356-363.
［13］Diedrich JT, Desai S, Zhao Q, et al. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction ［J］. Am J Obstet Gynecol，2015，212（1）:50.e 1-50.e 8.
［14］Eisenberg DL, Schreiber CA, Turok DK, et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system ［J］. Contraception，2015，92（1）:10-16.
［15］ANDERSSON K, ODLIND V, RYBO G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial ［J］. Contraception, 1994, 49 (1): 56-72.
［16］Liletta package insert［EB/OL］. http://pi.actavis.com/data_stream.asp?product_group=1960&p=pi&language=E (Accessed on April 24, 2015).
［17］韩丽晖．皮下埋植避孕的不良反应与治疗 ［J］．中国计划生育学杂志，2007，15（9）：573-574．
［18］《皮下埋植避孕方法临床应用专家共识》编写组.皮下埋植避孕方法临床应用专家共识 ［J］.中华妇产科杂志,2013,48 (6):476-480.
［19］HALDERMAN L D, LELSON A L. Impact of early postpartum administration of progestion-only hormonal contraceptives ancompared with nonhormonal contraceptives on short-term breast-feeding patters ［J］. American Journal of Obstetrics and Gynecology, 2002, 186 (6): 1250-1256.
［20］Department of Reproductive Health. Medical eligibility criteria for contraceptive use ［M］. 4th ed. Geneva: WHO press, 2009.
［21］TRUSSELL J. Contraceptive failure in the United States ［J］. Contraception, 2004, 70 (2): 89-96.
相似文献/References:
[1]白汝兰,邓睿,尹芳,等.寿命表法在放置IUD后随访中的运用[J].中国计划生育和妇产科,2009,(05):0.
BAI Ru-lan,DENG Rui,YIN Fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(1):0.
[2]彭英.Tcu380A与MLcu375宫内节育器临床效果比较[J].中国计划生育和妇产科,2009,(05):0.
[3]金炼.米非司酮配伍米索前列醇用于绝经后妇女取器50例临床分析[J].中国计划生育和妇产科,2009,(05):0.
[4]张蓉.宫内节育器异位于盆腔10例临床分析[J].中国计划生育和妇产科,2009,(05):0.
[5]杨学妞.难取节育器36例的处理及分析[J].中国计划生育和妇产科,2009,(05):0.
[6]陈晓勤,雷贞武,谢黎,等.三种避孕方法对妇女血清铁蛋白影响的研究[J].中国计划生育和妇产科,2009,(06):0.
CHEN Xiao-qin,LEI Zhen-wu,XIE Li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(1):0.
[7]吴文琼,罗建琼.两种含记忆合金新型IUD 24个月临床效果观察[J].中国计划生育和妇产科,2010,(01):0.
WU Wen-qiong,LUO Jian-qiong Service center for family planning in Wenjiang region of Chengdu city,Chengdu Sichuan 0,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(1):0.
[8]陈军,付容胜,纳果,等.三维超声检查宫内节育器应用分析[J].中国计划生育和妇产科,2010,(01):0.
[9]施成翠,李德琼.带器宫内外同时妊娠4例报道[J].中国计划生育和妇产科,2010,(02):0.
[10]张继,王素梅,刘瑞敏,等.米索前列醇在绝经后妇女宫内节育器取出术中的应用[J].中国计划生育和妇产科,2010,(03):0.